Your session is about to expire
← Back to Search
SQ tree SLIT-tablet for Allergy (TreeTop Trial)
TreeTop Trial Summary
This trial is testing whether the medication is effective and safe to treat birch/tree pollen allergy in children and adolescents.
TreeTop Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTreeTop Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.TreeTop Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is this research program looking for more participants?
"The information on clinicaltrials.gov suggests that this trial is looking for patients at this time. The trial was first announced on April 7th, 2021 and was last updated on August 12th, 2022."
Is there a potential for SQ tree SLIT-tablet to have negative side effects for users?
"Data from Phase 3 clinical trials provides evidence of SQ tree SLIT-tablet's efficacy and safety, thus it received a score of 3 from our team."
How many individuals are being given the chance to try this new treatment?
"The clinical trial is recruiting patients and the information is available on clinicaltrials.gov. The trial was first posted on 4/7/2021. It was last edited on 8/12/2022. They are looking for 1000 participants between 3 locations."
Are elderly patients eligible to participate in this experiment?
"In order to take part in this clinical trial, potential patients must fall between the ages of 5 and 17. Out of the 242 total trials, 80 are for those under 18 and 162 are for seniors."
Share this study with friends
Copy Link
Messenger